BRIEF-Genocea's Genital Herpes Immunotherapy GEN-003 demonstrates significant reduction of viral shedding in phase 2b clinical trial
Sept 29 Genocea Biosciences, Inc. :
* Study achieved its primary endpoint
* Genocea's Genital Herpes Immunotherapy GEN003 demonstrates significant reduction of viral shedding in phase 2b clinical trial
* Phase 3 expected to start in 2h 2017 Source text for Eikon: Further company coverage:
AT&T reaches deal to buy Time Warner for more than $80 billion -WSJ
Oct 22 AT&T Inc reached a deal to buy media company Time Warner Inc for more than $80 billion, The Wall Street Journal reported on Saturday.
Trump vows to weaken U.S. media 'power structure' if elected
GETTSYBURG, Pa. , Oct 22 U.S. Republican presidential candidate Donald Trump promised on Saturday to foil a proposed deal for AT&T Inc to buy Time Warner Inc if he wins the Nov. 8 election, arguing it was an example of a "power structure" rigged against both him and voters.